For example, EVs loaded with siRNA against the anti-apoptotic molecule, survivin, have been specifically delivered to prostate cancer cells in vivo using prostate-specific membrane antigen (PSMA) aptamers (76) (Table 3). This evidence concerns the gene FOLH1 and prostate carcinoma.